Cargando…
Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers
Radiation therapy remains an important component of cancer treatment. Gene-encoded proteins were the actual executors of cellular functions. Proteomic was a novel technology that can systematically analysis protein composition and measure their levels of change, this was a high throughput method, an...
Autores principales: | Luo, Hui, Ge, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904368/ https://www.ncbi.nlm.nih.gov/pubmed/35280744 http://dx.doi.org/10.3389/fonc.2022.852791 |
Ejemplares similares
-
An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
por: Kumar, Vipin, et al.
Publicado: (2020) -
Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
por: Sallam, Reem M.
Publicado: (2015) -
Editorial: Regulators of radiosensitivity in colorectal cancer
por: Bishnupuri, Kumar, et al.
Publicado: (2022) -
Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma
por: Xie, Yandong, et al.
Publicado: (2021) -
Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo
por: Xu, Ying, et al.
Publicado: (2021)